STOCK TITAN

Director-linked Treo Ventures buys 46,800 CVRx (CVRX) shares

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

CVRx director-associated entity reports open-market share purchase. Treo Ventures I, L.P., an entity for which director Mudit K. Jain is the general partner, bought 46,800 shares of CVRx common stock on February 20, 2026 at a weighted average price of $6.3588 per share, with individual prices ranging from $5.8500 to $6.3868. Jain also directly holds 5,650 common shares after these transactions.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jain Mudit K.

(Last) (First) (Middle)
9201 WEST BROADWAY AVE
SUITE 650

(Street)
MINNEAPOLIS MN 55445

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 P 46,800 A $6.3588(1) 980,183 I See footnote(2)
Common Stock 5,650 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects the weighted average price of 46,800 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on February 20, 2026 with purchase prices ranging from $5.8500 to $6.3868 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2. These shares are held directly by Treo Ventures I, L.P ("Treo"). The Reporting Person is the General Partner of Treo and shares voting and dispositive power over the shares held by Treo. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
/s/ Amy C. Seidel, Attorney-in-Fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the CVRx (CVRX) Form 4 filed by Mudit K. Jain report?

The Form 4 reports that Treo Ventures I, L.P., an entity associated with director Mudit K. Jain, purchased 46,800 CVRx common shares on February 20, 2026 in open-market transactions at a weighted average price of $6.3588 per share.

At what prices were the 46,800 CVRx (CVRX) shares purchased?

The 46,800 CVRx common shares were bought at a weighted average price of $6.3588. Individual open-market purchase prices on February 20, 2026 ranged from $5.8500 to $6.3868 per share, according to the reporting person’s disclosure.

Who actually holds the 46,800 CVRx (CVRX) shares reported in the Form 4?

The 46,800 shares are held by Treo Ventures I, L.P.. Director Mudit K. Jain is the general partner of Treo, shares voting and dispositive power over these shares, and disclaims beneficial ownership except to the extent of his pecuniary interest.

How many CVRx (CVRX) shares does Mudit K. Jain hold directly after the transactions?

After the reported transactions, Mudit K. Jain directly holds 5,650 shares of CVRx common stock. The additional 980,183 shares are reported as indirectly held through Treo Ventures I, L.P., reflecting his role as general partner.

What type of transaction was disclosed in the CVRx (CVRX) Form 4?

The Form 4 discloses an open-market purchase of CVRx common stock. The transaction code “P” indicates a purchase in open-market or private transactions, covering 46,800 shares acquired on February 20, 2026 by Treo Ventures I, L.P.
Cvrx, Inc.

NASDAQ:CVRX

CVRX Rankings

CVRX Latest News

CVRX Latest SEC Filings

CVRX Stock Data

160.76M
23.95M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MINNEAPOLIS